Circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage - PubMed (original) (raw)

doi: 10.1006/clim.2001.5060.

B M von Blomberg, N Nishi, M Reijm, A E Voskuyl, A A van Bodegraven, C H Polman, T Rustemeyer, P Lips, A J van den Eertwegh, G Giaccone, R J Scheper, H M Pinedo

Affiliations

• PMID: 11465942
• DOI: 10.1006/clim.2001.5060

Circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage

H J van der Vliet et al. Clin Immunol. 2001 Aug.

Abstract

Natural killer T (NKT) cells have been implicated as playing an important role in regulating immune responses. Defects in the NKT cell population were reported in animal autoimmune disease models and in distinct human autoimmune diseases. Here, we report that circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a broad variety of disorders with (auto)immune-mediated pathology, affecting the skin, bowel, central nervous system, and joints, regardless of disease duration or activity. Remarkably, normal circulating V(alpha24+) Vbeta11+ NKT cell numbers were found in Graves disease and coeliac disease. Since earlier studies noted a rise in NKT cells in myasthenia gravis, the picture emerges in which a defective NKT cell population is associated with autoreactive tissue damage rather than with the propensity to develop autoimmune disease. The present data support the idea that therapies aiming at the in vivo expansion of regulatory NKT cells might help to control immune-mediated damage in autoimmune disease.

Copyright 2001 Academic Press.

PubMed Disclaimer

Similar articles

• Tissue-specific expansion of NKT and CD5+B cells at the onset of autoimmune disease in (NZBxNZW)F1 mice.
  Morshed SR, Mannoor K, Halder RC, Kawamura H, Bannai M, Sekikawa H, Watanabe H, Abo T. Morshed SR, et al. Eur J Immunol. 2002 Sep;32(9):2551-61. doi: 10.1002/1521-4141(200209)32:9<2551::AID-IMMU2551>3.0.CO;2-C. Eur J Immunol. 2002. PMID: 12207339
• The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients.
  Konishi J, Yamazaki K, Yokouchi H, Shinagawa N, Iwabuchi K, Nishimura M. Konishi J, et al. Hum Immunol. 2004 Nov;65(11):1377-88. doi: 10.1016/j.humimm.2004.09.003. Hum Immunol. 2004. PMID: 15556688
• Resistance to malarial infection is achieved by the cooperation of NK1.1(+) and NK1.1(-) subsets of intermediate TCR cells which are constituents of innate immunity.
  Mannoor MK, Weerasinghe A, Halder RC, Reza S, Morshed M, Ariyasinghe A, Watanabe H, Sekikawa H, Abo T. Mannoor MK, et al. Cell Immunol. 2001 Aug 1;211(2):96-104. doi: 10.1006/cimm.2001.1833. Cell Immunol. 2001. PMID: 11591113
• The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice.
  Cardell SL. Cardell SL. Clin Exp Immunol. 2006 Feb;143(2):194-202. doi: 10.1111/j.1365-2249.2005.02942.x. Clin Exp Immunol. 2006. PMID: 16412042 Free PMC article. Review.
• The immunoregulatory role of CD1d-restricted natural killer T cells in disease.
  van der Vliet HJ, Molling JW, von Blomberg BM, Nishi N, Kölgen W, van den Eertwegh AJ, Pinedo HM, Giaccone G, Scheper RJ. van der Vliet HJ, et al. Clin Immunol. 2004 Jul;112(1):8-23. doi: 10.1016/j.clim.2004.03.003. Clin Immunol. 2004. PMID: 15207777 Review.

Cited by

• Farming, Foreign Holidays, and Vitamin D in Orkney.
  Weiss E, Zgaga L, Read S, Wild S, Dunlop MG, Campbell H, McQuillan R, Wilson JF. Weiss E, et al. PLoS One. 2016 May 17;11(5):e0155633. doi: 10.1371/journal.pone.0155633. eCollection 2016. PLoS One. 2016. PMID: 27187691 Free PMC article.
• Modulation of Tregs and iNKT by Fingolimod in Multiple Sclerosis Patients.
  Ferraro D, De Biasi S, Simone AM, Orlandi R, Nasi M, Vitetta F, Pinti M, Fogliani M, Meletti S, Cossarizza A, Sola P. Ferraro D, et al. Cells. 2021 Nov 26;10(12):3324. doi: 10.3390/cells10123324. Cells. 2021. PMID: 34943831 Free PMC article.
• Natural killer T cell defects in multiple myeloma and the impact of lenalidomide therapy.
  Chan AC, Neeson P, Leeansyah E, Tainton K, Quach H, Prince HM, Harrison SJ, Godfrey DI, Ritchie D, Berzins SP. Chan AC, et al. Clin Exp Immunol. 2014 Jan;175(1):49-58. doi: 10.1111/cei.12196. Clin Exp Immunol. 2014. PMID: 24032527 Free PMC article. Clinical Trial.
• Innate, innate-like and adaptive lymphocytes in the pathogenesis of MS and EAE.
  Van Kaer L, Postoak JL, Wang C, Yang G, Wu L. Van Kaer L, et al. Cell Mol Immunol. 2019 Jun;16(6):531-539. doi: 10.1038/s41423-019-0221-5. Epub 2019 Mar 15. Cell Mol Immunol. 2019. PMID: 30874627 Free PMC article. Review.
• Selective activation, expansion, and monitoring of human iNKT cells with a monoclonal antibody specific for the TCR alpha-chain CDR3 loop.
  Exley MA, Hou R, Shaulov A, Tonti E, Dellabona P, Casorati G, Akbari O, Akman HO, Greenfield EA, Gumperz JE, Boyson JE, Balk SP, Wilson SB. Exley MA, et al. Eur J Immunol. 2008 Jun;38(6):1756-66. doi: 10.1002/eji.200737389. Eur J Immunol. 2008. PMID: 18493987 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database